Zinc finger protein 24-dependent transcription factor SOX9 up-regulation protects tubular epithelial cells during acute kidney injury

Authors: Kim, Ji Young, Silvaroli, Josie A., Martinez, Gabriela Vasquez, Bisunke, Bijay, Luna Ramirez, Alanys V., Jayne, Laura A., Feng, Mei Ji He Ho, Girotra, Bhavya, Acosta Martinez, Shirely M., Vermillion, Corynne R., Karel, Isaac Z., Ferrell, Nicholas, Weisleder, Noah, Chung, Sangwoon, Christman, John W., Brooks, Craig R., Madhavan, Sethu M., Hoyt, Kari R., Cianciolo, Rachel E., Satoskar, Anjali A., Zepeda-Orozco, Diana, Sullivan, Jennifer C., Davidson, Alan J., Bajwa, Amandeep, Pabla, Navjot Singh

Source: Kidney international. 103(6):1093-1104

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190350519.0x000001&indx=1&recIds=ETOCvdc_100190350519.0x000001

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition

Authors: Bai, Yuntao, Kim, Ji Young, Bisunke, Bijay, Jayne, Laura A., Silvaroli, Josie A., Balzer, Michael S., Gandhi, Megha, Huang, Kevin M., Sander, Veronika, Prosek, Jason, Cianciolo, Rachel E., Baker, Sharyn D., Sparreboom, Alex, Jhaveri, Kenar D., Susztak, Katalin, Bajwa, Amandeep, Pabla, Navjot Singh

Source: In Kidney International December 2021 100(6):1214-1226

Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31

Authors: Silvaroli, Josie A., Bisunke, Bijay, Kim, Ji Young, Stayton, Amanda, Jayne, Laura A., Martinez, Shirely A., Nguyen, Christopher, Patel, Prisha S., Vanichapol, Thitinee, Verma, Vivek, Akhter, Juheb, Bolisetty, Subhashini, Madhavan, Sethu M., Kuscu, Cem, Coss, Christopher C., Zepeda-Orozco, Diana, Parikh, Samir V., Satoskar, Anjali A., Davidson, Alan J., Eason, James D., Szeto, Hazel H., Pabla, Navjot S., Bajwa, Amandeep

Source: Journal of the American Society of Nephrology; June 2024, Vol. 35 Issue: 6 p681-695, 15p

Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury.

Authors: Namwanje, Maria^1,2 (AUTHOR) glamani1@uthsc.edu, Bisunke, Bijay³ (AUTHOR) bbisunke@uthsc.edu, Rousselle, Thomas V.⁴ (AUTHOR) trousselle@som.umaryland.edu, Lamanilao, Gene G.² (AUTHOR) epatte18@uthsc.edu, Sunder, Venkatadri S.⁵ (AUTHOR) shyamuohyd@gmail.com, Patterson, Elizabeth C.² (AUTHOR) ckuscu@uthsc.edu, Kuscu, Canan² (AUTHOR) ckuscu1@uthsc.edu, Kuscu, Cem² (AUTHOR) jeason1@uthsc.edu, Maluf, Daniel⁶ (AUTHOR) dmaluf@som.umaryland.edu, Kiran, Manjari⁵ (AUTHOR) manjari.hcu@uohyd.ac.in, Mas, Valeria⁴ (AUTHOR) vmas@som.umaryland.edu, Eason, James D.² (AUTHOR), Bajwa, Amandeep^2,3,7 (AUTHOR) abajwa@uthsc.edu, Roselló-Catafau, Joan (AUTHOR)

Source: International Journal of Molecular Sciences. May2021, Vol. 22 Issue 10, p5386-5386. 1p.

Subject Terms: *RAPAMYCIN, *ACUTE kidney failure, *REPERFUSION injury, *LABORATORY mice, *KIDNEY physiology